Our products are approved as medicinal cannabis in Brazil under ANVISA

by Bold Commerce Collaborator February 19, 2020 1 min read

Our products are approved as medicinal cannabis in Brazil under ANVISA

We are proud to inform you that our CBD products have been approved for medicinal cannabis in Brazil under the ANVISA program, similar to the US FDA. This is a big statement by the Brazilian government, which shows their efforts to regulate the booming medical cannabis market and make sure that only the safest and highest quality products get sold to their citizens.

Thanks to our really high quality standards and the very low THC concentration of under 0.2% or even under 0.0% in our products, Formula Swiss is currently one of just three companies that can legally deliver CBD and medicinal cannabis to doctors and patients in Brazil. We deliver to patients in Brazil directly since over 6 months now.

Considering the market opportunity of 209 million people and more than 550.000 doctors, we are very excited and humbled by this opportunity. We hope to gain a big acceptance and trust from the Brazilian people in the near future.

You can read the full article about this at Forbes.com.
Bold Commerce Collaborator
Bold Commerce Collaborator


Leave a comment

Comments will be approved before showing up.


Also in News

Personal protective equipment (PPE) available for everyone
Personal protective equipment (PPE) available for everyone

by Formula Swiss April 30, 2020 2 min read

Read more
New pipette design in production
New pipette design in production

by Formula Swiss April 30, 2020 1 min read

Read more
Further flavours of our CBD Vape Oil now also available with 5% CBD
Further flavours of our CBD Vape Oil now also available with 5% CBD

by Formula Swiss April 15, 2020 1 min read

Read more
EUR